IMPACT OF DONOR DIVERSITY ON PHASE I AND PHASE II ACTIVITIES IN CRYOPRESERVED HUMAN HEPATOCYTES AND HUMAN LIVER MICROSOMES

被引：0
|
作者：
Bohl, Christopher [1 ]
Brouwer, Kenneth [2 ]
Heyward, Scott [3 ]
Cottier, Karissa [3 ]
Noah, Courtney [4 ]
Ogilvie, Brian [5 ]
机构：
[1] BioIVT, Kalamazoo, MI USA
[2] BioIVT, Durham, NC USA
[3] BioIVT, Baltimore, MD USA
[4] BioIVT, Hicksville, NY USA
[5] BioIVT, Kansas City, KS USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2024年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P27
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PREDICTION OF HUMAN CLEARANCE USING HUMAN LIVER MICROSOMES AND HEPATOCYTES WITH 455 DRUGS
    Tess, David
    Chang, George
    Keefer, Christopher
    Carlo, Anthony
    Jones, Rhys
    Di, Li
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
  • [32] Identification of 20(S)-Protopanaxadiol Metabolites in Human Liver Microsomes and Human Hepatocytes
    Li, Liang
    Chen, Xiaoyan
    Li, Dan
    Zhong, Dafang
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (03) : 472 - 483
  • [33] Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry
    Erve, John C. L.
    Vashishtha, Sarvesh C.
    DeMaio, William
    Talaat, Rasmy E.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (06) : 908 - 916
  • [34] In vitro evaluation of Boswella serrata extract as an inhibitor of cytochrome P450 (CYP) enzymes in cryopreserved human hepatocytes and human liver microsomes
    Roe, A. L.
    PLANTA MEDICA, 2014, 80 (10) : 849 - 849
  • [35] Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
    Brown, Hayley S.
    Griffin, Michael
    Houston, J. Brian
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (02) : 293 - 301
  • [36] Uptake transporter activities in 27 batches of cryopreserved suspended human hepatocytes
    Oorts, Marlies
    Nicolai, Johan
    Tolando, Roberto
    Richert, Lysiane
    Augustijns, Patrick
    Annaert, Pieter
    DRUG METABOLISM REVIEWS, 2016, 48 : 104 - 104
  • [37] A new in vitro approach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations
    Lahoz, Agustin
    Donata, Maria Teresa
    Montero, Sandra
    Castell, Jose V.
    Gomez-Lechon, Maria Jose
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2008, 22 (02) : 240 - 244
  • [38] Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544
    Gelardi, A
    Morini, F
    Dusatti, F
    Penco, S
    Ferro, M
    TOXICOLOGY IN VITRO, 2001, 15 (06) : 701 - 711
  • [39] The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials
    Edlund, C
    Nord, CE
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 : 37 - 41
  • [40] Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines
    Hallifax, D.
    Galetin, A.
    Houston, J. B.
    XENOBIOTICA, 2008, 38 (04) : 353 - 367
12345